Almost half of patients diagnosed with depression classify as being 'treatment-resistant' as new research suggests that many don't respond to multiple antidepressant options.

The 2023 death of celebrity Matthew Perry placed a spotlight on the dangers of ketamine, as it was determined to be the cause ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Francesca Jackson, 29, a spa therapist from Cheshire, medicated her feelings of anxiety, low self-worth, and fatigue with ...

It is one of the most common medical conditions in the world - yet we often don’t know what causes it, nor how best to treat ...

From medications to neuromodulation, lifestyle changes, and emerging therapies, understand the latest evidence and best practices for managing mental illness in pregnancy and postpartum.

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

The drug, also known under the brand name Ativan, is part of a class called benzodiazepines, which also includes Xanax and ...

A new study from King’s College London has found that most people who take selective serotonin reuptake inhibitors (SSRIs), a ...

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...

Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified ...